poisar

Stocks · News reference

CG Oncology Reports Third Quarter 2026 Financial Results and Provides Business Updates

Fiscal.ai

CG Oncology, Inc. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — CG Oncology, Inc. (CGON)

    Filed: 2026-11-16 AccNo: 0001193125-26-462199 Size: 17 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits